Table 1.
Study | Country | Study period | Age of the children (y) | No. of participants |
Matching control | Matching variables | Primary outcome | NOS score | |
---|---|---|---|---|---|---|---|---|---|
Case | Control | ||||||||
Preston-Martin et al., 1998 [34] | USA, France, Israel, and Europe | 1976-1994 | 0-19 | 1051 | 1919 | Varied by study centre | Age, sex, geographic region | CBT | 8 |
Wen et al., 2002 [26] | USA and Canada | 1989-1993 | <15 | 1842 | 1986 | Random-digit dialling | Age, sex | ALL | 8 |
Shaw et al., 2004 [27] | Canada | 1980-2000 | <15 | 789 | 789 | Population-based registry | Age, sex | ALL | 7 |
Ross et al., 2005 [30] | North America | 1997-2002 | <20 | 97 (ALL), 51 (AML) | 173 | Roster and birth registry | Age, sex | ALL, AML | 7 |
Schüz et al., 2007 [41] | Germany | 1992-1997 | 0-14 | 650 (ALL), 105 (AML), 399 (CBT), 157 (neuroblastoma), 147 (Wilms tumour), 97 (bone tumours), 137 (soft tissue sarcoma) | 2057 | Population-based registry | Sex, date of birth | ALL, AML, CBT, neuroblastoma, Wilms tumour, bone tumour, soft tissue sarcoma | 7 |
Johnson et al., 2009 [40] | USA and Canada | 1993-2001 | 0-15 | 278 | 423 | Random-digit dialling | Birth year, sex | Germ cell tumours | 8 |
Milne et al., 2010 [28] | Australia | 2003-2007 | 0-15 | 393 | 1249 | Random-digit dialling | Age, sex, state of residence | ALL | 7 |
Linabery et al., 2010 [31] | USA | 1996-2006 | <1 | 264 (ALL), 172 (AML) | 324 | State birth registry | Birth year, location of residence | ALL, AML | 7 |
Stålberg et al., 2010 [35] | Sweden | 1990-1999 | 0-15 | 512 | 525 | Medical birth register | Location, sex, birth year | CBT | 7 |
Ortega-García et al., 2010 [36] | Spain | 2004-2006 | 0-15 | 67 | 155 | Hospital record registry | Birth year | CBT | 8 |
Amigou et al., 2012 [18] | France | 2003-2004 | 0-15 | 764 | 1681 | Population-based registry | Age, sex, region | ALL | 7 |
Bailey et al., 2012 [29] | Australia | 2003-2006 | 0-14 | 333 | 695 | Random-digit dialling | Age, sex, state of residence | ALL | 8 |
Milne et al., 2012 [37] | Australia | 2005-2011 | 0-14 | 335 | 1363 | Random-digit dialling | Age, sex, state of residence | CBT | 7 |
Ajrouche et al., 2014 [32] | France | 2010-2011 | <15 | 636 (ALL), 100 (AML) | 1421 | Population-based registry, quota sampling method | Age, sex | ALL, AML | 8 |
Amitay et al., 2016 [39] | Israel | 2005-2013 | 1-19 | 121 (ALL), 69 (lymphoma) | 384 | Home communities | Age, sex | ALL, lymphoma | 7 |
Singer et al., 2016 [33] | USA (California) | 1995-2008 | 0-14 | 681 (ALL), 103 (AML) | 1076 | California birth certificates | Date of birth, sex, Hispanic ethnicity, maternal race | ALL, AML | 8 |
Bailey et al., 2017 [38] | France | 2010-2011 | <15 | 301 | 1421 | Population-based registry | Age, sex, region | CBT | 8 |
NOS, Newcastle-Ottawa Scale; CBT, childhood brain tumour; ALL, acute lymphoblastic leukaemia; AML, acute myeloid leukaemia.